Archives of Testimony to Congress

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current testimonies on nida.nih.gov.

Fiscal Year 2017 Budget Request

 |  Testimony by Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, before the House Subcommittee on Labor-HHS-Education Appropriations

Fiscal Year 2016 Budget Request

 |  Testimony by Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, before the House Subcommittee on Labor-HHS-Education Appropriations

Fiscal Year 2015 Budget Request

 |  Mr. Chairman and Members of the Committee: I am pleased to present the Fiscal Year (FY) 2015 President’s Budget Request for the National Institute on Drug Abuse (NIDA). The FY...

Prescription Opioid and Heroin Abuse

 |  Good Morning, Mr. Chairman and Members of the Subcommittee. Thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to...

Dangerous Synthetic Drugs

 |  Senate Caucus on International Narcotics Control to Hold Hearing on Dangerous Synthetic Drugs (United States Senate Caucus on International Narcotics Control) Introduction Madame Chairwoman and Members of the Caucus: Thank...

Fiscal Year 2013 Budget Request

 |  Introduction Mr. Chairman and Members of the Committee: I am pleased to present the President’s budget request for the National Institute on Drug Abuse (NIDA) of the National Institutes of...

Fiscal Year 2012 Budget Request

 |  Introduction Mr. Chairman and Members of the Committee: I am pleased to present the President's Fiscal year 2012 Budget Request for the National Institute on Drug Abuse (NIDA). The FY...

Prescription Drug Abuse

 |  Thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), an agency of the Department of Health and Human Services...

Fiscal Year 2011 Budget Request

 |  Introduction Drug abuse and addiction are a major burden to society, with economic costs alone estimated to exceed $600 billion annually in the United States (ONDCP 2004; Rehm et al...

Fiscal Year 2010 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's Fiscal Year 2010 Budget request for the National Institute on Drug Abuse...

Fiscal Year 2009 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's Budget for the National Institute on Drug Abuse (NIDA) of the National...

Fiscal Year 2008 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Subcommittee: I am pleased to present the Fiscal Year (FY) 2008 President's budget request for the National Institute on Drug...

Fiscal Year 2007 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Subcommittee: I am pleased to present the Fiscal Year (FY) 2007 President's budget request for the National Institute on Drug...

Methamphetamine Abuse

 |  Statement for the Record Mr. Chairman and Members of the Committee: Thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health...

Fiscal Year 2006 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the Fiscal Year (FY) 2006 President's budget request for the National Institute on Drug...

Fiscal Year 2005 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's budget request for the National Institute on Drug Abuse. The fiscal year...

Fiscal Year 2004 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's budget request for the National Institute on Drug Abuse. The fiscal year...

Research on MDMA

 |  Statement for the Record Mr. Chairman and Members of the Subcommittee, thank you for the opportunity to present scientific findings about Ecstasy or MDMA. I am Dr. Glen Hanson, the...

Fiscal Year 2003 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's budget request for the National Institute on Drug Abuse for FY 2003...

OxyContin: Balancing Risks and Benefits

 |  Statement for the Record Mr. Chairman and Members of the Committee, I am pleased to submit the following statement for the record discussing what we have come to learn about...

Ecstasy Abuse and Control

 |  Statement for the Record Mr. Chairman, and Members of the Committee, thank you for inviting me to participate in this important and timely hearing on MDMA. I am pleased with...

Continuing Concern Over Imported Pharmaceuticals

 |  Summary Statement Many substances can be very effective medications when used properly, but highly addictive, dangerous, substances when misused. Morphine exemplifies this point. Morphine is a powerfully addictive drug. However...

Fiscal Year 2002 Budget Request

 |  Mr. Chairman, and Members of the Committee: Statement for the Record I am pleased to present the President's budget request for the National Institute on Drug Abuse, a sum of...

Fiscal Year 2001 Budget Request

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to present the President's non-AIDS budget request for the National Institute on Drug Abuse (NIDA) for...

Heroin Abuse and Addiction

 |  Statement for the Record Thank you for inviting me to participate in this important hearing. I am Dr. Alan I. Leshner, the Director of the National Institute on Drug Abuse...

The Drug Addiction Treatment Act of 1999

 |  Statement for the Record There is a tremendous need to develop new and effective medications for drug addiction and to increase access to treatment. This is articulated by a number...

Drug Legalization

 |  Statement for the Record Thank you for inviting me to participate in this hearing. What I would like to do this morning is illustrate through the use of some recent...

Hearing on Youth Media Campaign

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to be here with my distinguished colleagues to discuss the role of the National Institute on...

Formal Statement on NIDA Research

 |  Statement for the Record Mr. Chairman and Members of the Committee: I am pleased to be part of this distinguished panel to share with you what science has come to...

Statement on GHB

 |  Statement for the Record Mr. Chairman and Members of the Subcommittee, I am Dr. Stephen Zukin, Director of the Division of Clinical and Services Research at the National Institute on...

Fiscal Year 2000 Budget Request

 |  Statement of the Director Mr. Chairman and Members of the Committee: I am pleased to present the President's budget request for the National Institute on Drug Abuse for Fiscal Year...

Fiscal Year 1999 Budget Request

 |  The President in his FY 1999 budget has proposed that the National Institute on Drug Abuse receive $395.1 million, an increase of $35.3 million over the comparable 1998 appropriation. Including the estimated allocation for AIDS, total support provided for NIDA is $576.3 million an increase of $49.1 million over the FY 1998 appropriation. Funds for NIDA efforts in AIDS research are included within the Office of AIDS Research budget request.

Statement on Nicotine

 |  Statement of the Director Mr. Chairman and Members of the Committee, I am pleased to be here with my distinguished colleagues to discuss current research findings and future research directions...

Statement on Children's Health Issues

 |  Statement for the Record Mr. Chairman and Members of the Subcommittee, I am pleased to be here with my distinguished colleagues to discuss current research findings and future research directions...